Cartesian Therapeutics Inc.
03/30/2026 | Press release | Distributed by Public on 03/30/2026 15:44
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On March 26, 2026, Murat Kalayoglu, M.D., Ph.D., a member of the Board of Directors (the "Board") of Cartesian Therapeutics, Inc. (the "Company"), notified the Company of his intent to resign from the Board, effective as of March 31, 2026, to pursue other opportunities. Prior to his resignation, Dr. Kalayoglu served as Chairman of the Board's Science and Technology Committee and as a member of the Board's Nominating and Corporate Governance Committee. In connection with his resignation from the Board, Dr. Kalayoglu will cease service on such committees. Dr. Kalayoglu's resignation was not the result of a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Dr. Kalayoglu served on the Board since 2023. The Company thanks Dr. Kalayoglu for his advice and leadership as a member of the Board and wishes Dr. Kalayoglu well as he pursues other opportunities.
Cartesian Therapeutics Inc. published this content on March 30, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 30, 2026 at 21:46 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]